sexta-feira, 16 de julho de 2010

Conf de Theo Thepen: Immunotoxins as therapeutic alternative in leishmaniasis


Dr. Theo Thepen, do Fraunhofer Institute (Aachen), colaborador internacional do LIMI, proferirá conferência no Centro de Pesquisas Gonçalo Moniz (CPqGM; FIOCRUZ-Bahia) intitulada:
"Immunotoxins as therapeutic alternative in leishmaniasis"
A conferência será dia 20 de julho (3a-f) às 14’00, no Auditório do CPqGM.
Veja alguns dados do Dr. Thepen, da sua página no Fraunhofer Institute:
Description
University Training:
01-08-1980 - 12-12-1987
Medical Biology, Vrije Universiteit, Amsterdam, the Netherlands
PhD: 01-12-1987 - 25-01-1992, Department of Cell biology/Immunology, Vrije Universiteit, Amsterdam, the Netherlands. Title PhD thesis: 'Regulation of Pulmonary Immune responses by Alveolar Macrophages'. 
Research Fellow:
01-04-1989 - 15-10-1989 (Travel grant VU)
01-11-1990 - 01-04-1991 (Travel grant NWO), The Department of Immunology, Western Australian Research Institute of Child Health, Princess Margaret Children’s Hospital, Perth, Western Australia 
Relevant work experience:
Postdoc 25-01-1992 - 01-07-1992, Department of Cell biology/Immunology, Vrije Universiteit, Amsterdam.
Postdoc 01-07-1992 - 31-03-1994, Dep. Dermatology /Allergology, Academic Hospital Utrecht.
University Lecturer / Assistant Professor: 01-04-1994 - 31-06-1997, Dep.Dermatology/Allergology, Academic Hospital Utrecht.
Senior Scientist: 01-04-1997 - 31-06-2002, Department of Immunotherapy, University Medical Centre Utrecht / Medarex Europe BV
Principal Scientist: 01-07-2002 - 31-06-2003, Department of Pharmacy, Utrecht University, Utrecht /Medarex Inc, Annandale, USA.
Principal Scientist: 01-07-2003 - present, Fraunhofer IME, Aachen
Projects:
  • Accelerated Drug Development (IMHOTEP)
  • Immunochemistry
  • Imaging and Molecular imaging
  • Animal models
Veja as 10 publicações mais recentes do Dr. Thepen, no PubMed:
Kampmeier F, Niesen J, Koers A, Ribbert M, Brecht A, Fischer R, Kießling F, Barth S, Thepen T.
Eur J Nucl Med Mol Imaging. 2010 May 7. [Epub ahead of print]
Ribbert T, Thepen T, Tur MK, Fischer R, Huhn M, Barth S.
Br J Dermatol. 2010 Apr 26. [Epub ahead of print]
Thepen T, Huhn M, Melmer G, Tur MK, Barth S.
Curr Pharm Des. 2009;15(23):2712-8. Review.
Ranft K, Thepen T, Fischer R, Barth S, Stöcker M.
Cancer Lett. 2009 Sep 18;282(2):187-94. Epub 2009 Apr 3.
Stahnke B, Thepen T, Stöcker M, Rosinke R, Jost E, Fischer R, Tur MK, Barth S.
Mol Cancer Ther. 2008 Sep;7(9):2924-32.
Nachreiner T, Kampmeier F, Thepen T, Fischer R, Barth S, Stöcker M.
J Neuroimmunol. 2008 Mar;195(1-2):28-35. Epub 2008 Feb 15.
van Vuuren AJ, van Roon JA, Walraven V, Stuij I, Harmsen MC, McLaughlin PM, van de Winkel JG, Thepen T.
J Immunol. 2006 May 15;176(10):5833-8.
Paetz A, Sack M, Thepen T, Tur MK, Bruell D, Finnern R, Fischer R, Barth S.
Biochem Biophys Res Commun. 2005 Dec 30;338(4):1811-7. Epub 2005 Nov 2.
Samsom JN, van Berkel LA, van Helvoort JM, Unger WW, Jansen W, Thepen T, Mebius RE, Verbeek SS, Kraal G.
J Immunol. 2005 May 1;174(9):5279-87.
Leemans JC, Thepen T, Weijer S, Florquin S, van Rooijen N, van de Winkel JG, van der Poll T.
J Infect Dis. 2005 Jan 1;191(1):65-74. Epub 2004 Nov 29.

Nenhum comentário:

Postar um comentário